ZimVie separation completed

Zimmer Biomet’s spine and dental spinoff, ZimVie, completed its separation on schedule March 1.

Advertisement

The March 1 separation date was given in February alongside Zimmer Biomet’s fourth quarter results. ZimVie shares will begin trading on the Nasdaq under the symbol “ZIMV,” according to a March 1 news release.

Vafa Jamali, who previously worked at Medtronic, leads ZimVie as CEO. The independent spinoff company was first announced in February 2021.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.